Drugs and Drug Candidates is a peer-reviewed english-language open-access journal published by MDPI AG in Switzerland, operating under an open-access model since 2022. The journal covers Pharmacy and materia medica and Chemistry.
Authors are required to pay an article processing charge to publish in Drugs and Drug Candidates; refer to the journal's APC page for the current rate. Articles are released under the CC BY license (see other journals using this license).
To date, Drugs and Drug Candidates has published 189 articles. Articles are minted with DOIs through the prefix 10.3390. All submissions undergo plagiarism screening before peer review.
Keywords
marketed drugs, drugs, drug industry, pharmacology
At a glance
- Publisher
- MDPI AG
- Country
- Switzerland
- Primary language
- English
- License
- CC BY
- Peer review
- Anonymous peer review
- OA since
- 2022
- Review time
- 6 weeks
- DOI prefix
10.3390- Plagiarism check
- Yes
ISSN
- electronic
- 2813-2998
Frequently asked questions
Is Drugs and Drug Candidates peer-reviewed?
Yes — Drugs and Drug Candidates operates a Anonymous peer review review process.
Does Drugs and Drug Candidates charge an article processing charge (APC)?
Yes — refer to the journal's APC page for the current rate.
What subjects does Drugs and Drug Candidates publish?
Drugs and Drug Candidates publishes research in Pharmacy and materia medica and Chemistry.
What languages does Drugs and Drug Candidates accept?
Drugs and Drug Candidates accepts manuscripts in English.
What is the ISSN of Drugs and Drug Candidates?
ISSN:
2813-2998 (electronic).How do I submit a manuscript to Drugs and Drug Candidates?
Submit through the journal's official portal: visit submission page →
How long does peer review take at Drugs and Drug Candidates?
Average time from submission to publication is approximately 6 weeks.